简体
  • 简体中文
  • 繁体中文

热门资讯> 正文

Evogene未能达到第一季度的预期

2026-05-20 19:06

  • Evogene press release (EVGN): Q1 GAAP EPS of -$0.60 misses by $0.33.
  • Revenue of $0.3M (-100.0% Y/Y) misses by $0.05M.
  •  As of March 31, 2026, Evogene held consolidated cash, cash equivalents, and short-term bank deposits of approximately $13.1 million. The consolidated cash usage during the first quarter of 2026 was approximately $2.8 million.

风险及免责提示:以上内容仅代表作者的个人立场和观点,不代表华盛的任何立场,华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前,应结合自身情况,考虑投资产品的风险。必要时,请咨询专业投资顾问的意见。华盛不提供任何投资建议,对此亦不做任何承诺和保证。